| Meiji Seika Pharma Co., Ltd. Patent applications |
| Patent application number | Title | Published |
|---|
| 20120100578 | CELLULASE PREPARATION COMPRISING ENDOGLUCANASES DERIVED FROM TWO DIFFERENT TYPES OF MICROORGANISMS - By having a cellulase preparation comprising at least a certain amount of endoglucanases derived from two different types of microorganisms, the cellulase preparation can be provided with a higher activity and a wider pH property than those of cellulase preparations each containing one of the endoglucanases alone. Moreover, by introducing and expressing simultaneously two different types of cellulase genes in a single host cell, a cellulase preparation having a high activity and a wide pH property can be produced easily. | 04-26-2012 |
| 20120100105 | AGENT AND METHOD FOR TREATING REFRACTORY CHRONIC HEPATITIS C - It is found that even refractory chronic hepatitis C can be treated effectively and safely by administering an effective amount of a combination of 22β-methoxyolean-12-ene-3β,24(4β)-diol with an IFN. | 04-26-2012 |
| 20110294192 | FUSION COLLAGENASE IN WHICH AFFINITY TAG IS LINKED AND METHOD FOR PRODUCING THE SAME - A fusion collagenase in which an affinity tag is added to the carboxyl terminal of a collagenase was expressed as a recombinant protein. It was found that a collagenase having a collagen-binding domain can be selectively collected by purifying the obtained fusion collagenase by affinity chromatography. | 12-01-2011 |
| 20110263608 | 16-KETO ASPERGILLIMIDES AND HARMFUL ORGANISM CONTROL AGENT COMPRISING THE SAME AS ACTIVE INGREDIENT - Disclosed is a composition for use in controlling ectoparasites, comprising as an active ingredient at least one of compounds represented by formula (I) or (III) or salts thereof. The present invention provides a composition for use in controlling ectoparasites that has excellent ectoparasite control effect and is highly safe. | 10-27-2011 |
